Ark Genomic Revolution ETF (ARKG)
$93.51
0.38 (0.41%)
20:00 EST
ARKG Stock Quote Delayed 30 Minutes
Previous Close
-
Market Cap
299.72M
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
7.73M
Day's Range
90.17 - 95.48
52-Week Range
24.00 - 115.15
Dividend & Yield
N/A (N/A)
ARKG Stock Predictions, Articles, and Ark Genomic Revolution ETF News
- From InvestorPlace
- From the Web
Ark Invest Funds: Why ARKG, ARKF, ARKQ and the ARKK ETF Are Stumbling
Ark Invest funds like the ARKK ETF are falling today thanks to big bets on Tesla and Bitcoin. Here's why the big picture is still bright.
5 of 2020’s Best ETFs to Buy
There are plenty of exciting funds this year, but clean energy and other thematic ideas are among the best ETFs of 2020.
3 Healthcare ETFs to Buy for Health and Safety
Not all healthcare ETFs are the same and as this group of three proves, that can be a positive for savvy investors.
How to Find the Top Stocks in the Hottest Sectors
Here's how a sector fund can help you find top stocks in sizzling sectors. They’re a great place to start, especially when you want to gain exposure to a specific hypergrowth trend.
7 Biotech ETFs to Buy Now For Covid-19 And Beyond
Biotech ETFs are popular and delivering for investors, but not all of these funds need the Covid-19 pandemic to soar.
7 Healthcare ETFs Which Should Continue Growing Into 2021
Between the novel coronavirus and an election year, these healthcare ETFs appear poised to post strong growth into 2021.
7 of the Best Healthcare ETFs to Purchase for 2020
Don't ignore healthcare stocks because 2020 is an election year. Some of these funds are poised for big upside.
7 of the Best Healthcare ETFs to Purchase for 2020
Don't ignore healthcare stocks because 2020 is an election year. Some of these funds are poised for big upside.
3 of the Best Biotech ETFs on the Market
The fourth quarter has been a different story. IBB, the largest biotech ETF by assets, is up 16.65% since Oct. 1, pushing its year-to-date gain to 26.57% as of Dec. 20. That after months of investors pulling money from actively managed biotech funds, but that situation is starting to correct as well as data out this month indicate investors are warming to biotech assets again.
7 Biotech ETFs That Should Remain Healthy
The healthcare sector has been the worst performing on the S&P 500 in 2019, but these biotech ETFs are still worth a look.
7 of the Best Biotech ETFs
Amid ongoing industry consolidation, attractive valuations and a strong broad market, catalysts are in place for more upside for biotech ETFs.
7 Biotech ETFs to Consider for 2019
Biotech ETFs lagged in 2018, but that doesn't mean there aren't healthcare funds to consider for 2019.
5 ETFs to Buy to Play the New Economy
The new economy is here with the break-neck pace of innovation. With that, these are five ETFs to buy for the Fourth Industrial Revolution.
4 Sector ETFs That Beat the Market in August
We have highlighted four sector ETFs that easily crushed the market in August and could be better plays in the months ahead should the trends prevail. Compare B....
8 ETFs Up More Than 25% YTD
We highlight eight ETFs that have outperformed and gained more than 25% in the year-to-date time frame. Compare Brokers....
4 Best-Performing Sector ETFs from May
We have highlighted four sector ETFs that have gained handsomely in May and could be better plays in the months ahead should the trends prevail. Compare Brokers....
5 Biotech ETFs for Outsized Gains
Data support the notion that biotechnology stocks offer outperformance potential over diversified healthcare benchmarks. And these 5 biotech ETFs are a great to play the space.
The 10 Best ETFs of January 2018
These were the some of the best ETFs in January. Each outperformed the S&P 500 by at least 5% or more. Here's what investors need to know about each ETF.
